{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:58:57Z","timestamp":1786993137989,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"2016 Guangzhou major project of industry-university-research cooperative innovation","award":["201604020102"],"award-info":[{"award-number":["201604020102"]}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jogoh.2018.03.010","type":"journal-article","created":{"date-parts":[[2018,3,30]],"date-time":"2018-03-30T20:40:05Z","timestamp":1522442405000},"page":"227-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125"],"prefix":"10.1016","volume":"47","author":[{"given":"Xin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiwu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2018.03.010_bib0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Rebelo","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5 \u2013 a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2014.10.023","article-title":"Ovarian cancer in the United States: contemporary patterns of care associated with improved survival","volume":"136","author":"Cliby","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00404-013-2722-2","article-title":"Evaluation of HE4 as an extra biomarker to CA125 to improve detection of ovarian carcinoma: is it time for step forward?","volume":"288","author":"Azzam","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clinbiochem.2011.04.011","article-title":"Diagnostic performance of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases","volume":"44","author":"Park","year":"2011","journal-title":"Clin Biochem"},{"issue":"6","key":"10.1016\/j.jogoh.2018.03.010_bib0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ajog.2008.12.042","article-title":"Validation of serum biomarkers for detection of early-stage ovarian cancer","volume":"200","author":"Nosov","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0035","first-page":"38","volume":"27","author":"Wei","year":"2015","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"10.1016\/j.jogoh.2018.03.010_bib0040","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317691189","article-title":"Postoperative human epididymis protein 4 predicts primary therapy outcome in advanced epithelial ovarian cancer","volume":"39","author":"Vallius","year":"2017","journal-title":"Tumour Biol"},{"issue":"11","key":"10.1016\/j.jogoh.2018.03.010_bib0045","doi-asserted-by":"crossref","first-page":"14765","DOI":"10.1007\/s13277-016-5335-0","article-title":"Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer","volume":"37","author":"Shen","year":"2016","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.jogoh.2018.03.010_bib0050","first-page":"605","article-title":"HE4 \u2013 a novel promising serum marker in the diagnosis of ovarian carcinoma","volume":"32","author":"Langm\u00e1r","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"issue":"1","key":"10.1016\/j.jogoh.2018.03.010_bib0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jog.13181","article-title":"Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer","volume":"43","author":"Lee","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"10.1016\/j.jogoh.2018.03.010_bib0060","first-page":"4483","article-title":"Does human epididymis protein 4 (HE4) have a role in prediction of recurrent epithelial ovarian cancer","volume":"17","author":"Innao","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.jogoh.2018.03.010_bib0065","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.3892\/ol.2016.4533","article-title":"Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer","volume":"11","author":"Steffensen","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0070","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1158\/0008-5472.CAN-04-0746","article-title":"Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0075","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1349-7006.2007.00576.x","article-title":"Reduced transthyretin expression in sera of lung cancer","volume":"98","author":"Liu","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0080","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1158\/0008-5472.1114.65.3","article-title":"Transthyretin, a biomarker for nutritional status and ovarian cancer","volume":"65","author":"Schweigert","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0085","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1002\/pmic.200500093","article-title":"Characterization of serum biomarkers for detection of early stage ovarian cancer","volume":"5","author":"Kozak","year":"2005","journal-title":"Proteomics"},{"issue":"17","key":"10.1016\/j.jogoh.2018.03.010_bib0090","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1002\/pmic.200500093","article-title":"Characterization of serum biomarkers for detection of early stage ovarian cancer","volume":"5","author":"Kozak","year":"2005","journal-title":"Proteomics"},{"issue":"9","key":"10.1016\/j.jogoh.2018.03.010_bib0095","doi-asserted-by":"crossref","first-page":"e44960","DOI":"10.1371\/journal.pone.0044960","article-title":"Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.07.049","article-title":"Validation of serum biomarkers for detection of early- and late-stage endometrial cancer","volume":"202","author":"Farias-Eisner","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2018.03.010_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717302623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784717302623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T12:40:00Z","timestamp":1660740000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784717302623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2468784717302623"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2018.03.010","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2018.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}